SEC Filing Summary: PerkinElmer, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by PerkinElmer, Inc. on October 25, 2012. The report serves to announce the company's financial results for the quarter ended September 30, 2012. The filing references a press release (Exhibit 99.1) containing the full details of the announcement.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is furnished but not included in the text of this summary.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its legal incorporation into other filings.
Key Facts for Investor Verification
- Verify the specific revenue and earnings figures in the attached press release (Exhibit 99.1) as they are not listed in the 8-K body.
- Confirm the company's full-year 2012 guidance provided in the press release.
- Note that the registrant is PerkinElmer, Inc., not Revvity, Inc. (Revvity is a later corporate evolution of PerkinElmer's Life Sciences business).
- Review the press release for any segment-specific performance details or currency impact disclosures.